Literature DB >> 19576838

Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: prognostic impact may depend on type of treatment and stage of disease.

Luitpold V Distel1, Rainer Fickenscher, Katrin Dietel, Alexander Hung, Heiner Iro, Johannes Zenk, Emeka Nkenke, Maike Büttner, Gerald Niedobitek, Gerhard G Grabenbauer.   

Abstract

he purpose of this study was to evaluate the prognostic influence of various subtypes of tumour infiltrating lymphocytes (TIL) in head and neck cancer, in particular the potential influence of regulatory T cells (Treg) in relation to different treatment modalities was addressed. A total of 115 patients with squamous cell carcinoma of the oro- and hypopharynx were selected. A low-risk group of 62 patients with early disease was treated by primary surgery followed by external radiotherapy. A high-risk group of 53 inoperable patients with advanced disease was treated by primary radiochemotherapy. Two-hundred and forty biopsy samples were evaluated by use of the tissue-micro-array technique employing the following markers: CD3, CD4, CD8, CD20, CD68, FOXP3, Granzyme B. In the low-risk group high CD20+ infiltration was associated with a significantly better NED-survival rate (p=0.02). Contrary, among high-risk patients low CD20+ counts indicated significantly better survival (p=0.03). Additionally, in the low-risk group higher numbers of intraepithelial CD8+ TIL (>66.6 per thousand) led to improved NED-survival of 95% vs. 52% (p=0.005). The impact of TIL on prognosis in patients with head and neck cancer may be affected by type of treatment and stage of disease. This finding will influence future studies on the role of TIL in human cancers.

Entities:  

Mesh:

Year:  2009        PMID: 19576838     DOI: 10.1016/j.oraloncology.2009.05.640

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  45 in total

Review 1.  The secret ally: immunostimulation by anticancer drugs.

Authors:  Lorenzo Galluzzi; Laura Senovilla; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2012-02-03       Impact factor: 84.694

2.  Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.

Authors:  Bangrong Cao; Qifeng Wang; Huan Zhang; Guiquan Zhu; Jinyi Lang
Journal:  Oncoimmunology       Date:  2017-11-06       Impact factor: 8.110

3.  Prognostic value of CD45 transcriptional expression in head and neck cancer.

Authors:  Mercedes Camacho; Adriana Agüero; Anna Sumarroca; Laura López; Miguel-Ángel Pavón; Francesc-Xavier Avilés-Jurado; Jacinto García; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-25       Impact factor: 2.503

Review 4.  Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.

Authors:  Caroline Jochems; Jeffrey Schlom
Journal:  Exp Biol Med (Maywood)       Date:  2011-04-12

5.  Cell-to-cell distances between tumor-infiltrating inflammatory cells have the potential to distinguish functionally active from suppressed inflammatory cells.

Authors:  S Nagl; M Haas; G Lahmer; M Büttner-Herold; G G Grabenbauer; R Fietkau; L V Distel
Journal:  Oncoimmunology       Date:  2016-01-13       Impact factor: 8.110

6.  Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.

Authors:  Nghia Nguyen; Emily Bellile; Daffyd Thomas; Jonathan McHugh; Laura Rozek; Shama Virani; Lisa Peterson; Thomas E Carey; Heather Walline; Jeffery Moyer; Matthew Spector; Daniel Perim; Mark Prince; Scott McLean; Carol R Bradford; Jeremy M G Taylor; Gregory T Wolf
Journal:  Head Neck       Date:  2016-02-16       Impact factor: 3.147

Review 7.  Exploiting the curative potential of adoptive T-cell therapy for cancer.

Authors:  Christian S Hinrichs; Steven A Rosenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

8.  Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma.

Authors:  Sm Russell; Te Angell; Mg Lechner; Dj Liebertz; Aj Correa; Uk Sinha; N Kokot; Al Epstein
Journal:  Head Neck Oncol       Date:  2013-02-27

9.  Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clinical significance.

Authors:  C Tanchot; M Terme; H Pere; T Tran; N Benhamouda; M Strioga; C Banissi; L Galluzzi; G Kroemer; E Tartour
Journal:  Cancer Microenviron       Date:  2012-10-27

10.  Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.

Authors:  Malgorzata Harasymczuk; William Gooding; Aleksandra Kruk-Zagajewska; Jerzy Wojtowicz; Grzegorz Dworacki; Hanna Tomczak; Witold Szyfter; Theresa L Whiteside
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.